DK1778623T3 - Derivater af 1-phenylalkancarboxylsyrer til behandling af neurodegenerative sygdomme - Google Patents

Derivater af 1-phenylalkancarboxylsyrer til behandling af neurodegenerative sygdomme

Info

Publication number
DK1778623T3
DK1778623T3 DK05767873T DK05767873T DK1778623T3 DK 1778623 T3 DK1778623 T3 DK 1778623T3 DK 05767873 T DK05767873 T DK 05767873T DK 05767873 T DK05767873 T DK 05767873T DK 1778623 T3 DK1778623 T3 DK 1778623T3
Authority
DK
Denmark
Prior art keywords
treatment
neurodegenerative diseases
derivatives
phenylalkanecarboxylic acids
phenylalkanecarboxylic
Prior art date
Application number
DK05767873T
Other languages
English (en)
Inventor
Luca Raveglia
Ilaria Peretto
Stefano Radaelli
Bruno Pietro Imbimbo
Andrea Rizzi
Gino Villetti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of DK1778623T3 publication Critical patent/DK1778623T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
DK05767873T 2004-08-03 2005-07-26 Derivater af 1-phenylalkancarboxylsyrer til behandling af neurodegenerative sygdomme DK1778623T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04425604 2004-08-03
PCT/IB2005/002189 WO2006016219A2 (en) 2004-08-03 2005-07-26 Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
DK1778623T3 true DK1778623T3 (da) 2008-10-20

Family

ID=35462580

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05767873T DK1778623T3 (da) 2004-08-03 2005-07-26 Derivater af 1-phenylalkancarboxylsyrer til behandling af neurodegenerative sygdomme

Country Status (22)

Country Link
US (1) US7531692B2 (da)
EP (1) EP1778623B1 (da)
JP (1) JP4866851B2 (da)
KR (1) KR101156393B1 (da)
CN (1) CN1984878B (da)
AT (1) ATE399758T1 (da)
AU (1) AU2005270949B2 (da)
BR (1) BRPI0513647A (da)
CA (1) CA2576009C (da)
CY (1) CY1110401T1 (da)
DE (1) DE602005007912D1 (da)
DK (1) DK1778623T3 (da)
ES (1) ES2309778T3 (da)
HK (1) HK1104280A1 (da)
HR (1) HRP20080494T3 (da)
NO (1) NO339921B1 (da)
PL (1) PL1778623T3 (da)
PT (1) PT1778623E (da)
RS (1) RS50601B (da)
SI (1) SI1778623T1 (da)
WO (1) WO2006016219A2 (da)
ZA (1) ZA200700945B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101088272B1 (ko) 2003-02-21 2011-11-30 키에시 파르마슈티시 엣스. 피. 에이. 신경 퇴행성 질환의 치료를 위한 1-페닐알캔카복실산추출물
ES2526522T3 (es) 2010-04-21 2015-01-13 Chiesi Farmaceutici S.P.A. Derivados del ácido 1-(2-fluorobifenil-4-il)alquil carboxílico para la terapia de la amiloidosis transtiretina
CA2801449A1 (en) 2010-06-04 2011-12-08 Chiesi Farmaceutici S.P.A. 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the therapy of prion diseases
US9592210B2 (en) 2011-12-22 2017-03-14 Chiesi Farmaceutici S.P.A. 1-phenylalkanecarboxylic acid derivatives for the treatment of cognitive impairment
CA2869418A1 (en) 2012-04-04 2013-10-10 Chiesi Farmaceutici S.P.A. Derivatives of 1-(2-halo-biphenyl-4-yl)- alkanecarboxylic acids for the treatment of neurodegenerative diseases
US20150335596A1 (en) 2014-05-26 2015-11-26 Chiesi Farmaceutici S.P.A. 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the treatment of down's syndrome
EP3710444B1 (en) 2017-11-14 2023-04-12 Merck Sharp & Dohme LLC Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
US11498904B2 (en) 2017-11-14 2022-11-15 Merck Sharp & Dohme Llc Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
US6211235B1 (en) * 1996-11-22 2001-04-03 Elan Pharmaceuticals, Inc. Compounds for inhibiting β-amyloid peptide release and/or its synthesis
US6191166B1 (en) * 1997-11-21 2001-02-20 Elan Pharmaceuticals, Inc. Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis
US6117901A (en) * 1996-11-22 2000-09-12 Athena Neurosciences, Inc. N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use
AU8191998A (en) 1997-02-04 1998-08-25 Trega Biosciences, Inc. 4-substituted-quinoline derivatives and 4-substitute-quinoline combinatorial libraries
US5994379A (en) * 1998-02-13 1999-11-30 Merck Frosst Canada, Inc. Bisaryl COX-2 inhibiting compounds, compositions and methods of use
FR2842523A1 (fr) * 2002-07-17 2004-01-23 Sanofi Synthelabo Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
KR101088272B1 (ko) 2003-02-21 2011-11-30 키에시 파르마슈티시 엣스. 피. 에이. 신경 퇴행성 질환의 치료를 위한 1-페닐알캔카복실산추출물

Also Published As

Publication number Publication date
NO20070665L (no) 2007-05-02
US20080096968A1 (en) 2008-04-24
CY1110401T1 (el) 2015-04-29
EP1778623A2 (en) 2007-05-02
RS50601B (sr) 2010-05-07
ES2309778T3 (es) 2008-12-16
CN1984878B (zh) 2011-06-08
NO339921B1 (no) 2017-02-13
BRPI0513647A (pt) 2008-05-13
PT1778623E (pt) 2008-09-29
ATE399758T1 (de) 2008-07-15
WO2006016219A3 (en) 2006-04-27
DE602005007912D1 (de) 2008-08-14
CA2576009C (en) 2013-02-26
PL1778623T3 (pl) 2008-12-31
US7531692B2 (en) 2009-05-12
SI1778623T1 (sl) 2008-10-31
CN1984878A (zh) 2007-06-20
AU2005270949A1 (en) 2006-02-16
AU2005270949B2 (en) 2011-02-03
JP4866851B2 (ja) 2012-02-01
KR20070038982A (ko) 2007-04-11
HRP20080494T3 (en) 2008-11-30
WO2006016219A2 (en) 2006-02-16
ZA200700945B (en) 2008-09-25
CA2576009A1 (en) 2006-02-16
JP2008509124A (ja) 2008-03-27
HK1104280A1 (en) 2008-01-11
EP1778623B1 (en) 2008-07-02
KR101156393B1 (ko) 2012-06-13

Similar Documents

Publication Publication Date Title
NO20053855L (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
EA200901373A1 (ru) Аминогетероциклические соединения
EP1841426A4 (en) TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE
WO2005004803A3 (en) Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
DK1778623T3 (da) Derivater af 1-phenylalkancarboxylsyrer til behandling af neurodegenerative sygdomme
WO2005065195A3 (en) Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease
NO20063193L (no) Fusjonerte pyrrolokarbazoler og fremgangsmater for fremstilling derav
WO2006078576A3 (en) Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
WO2005051914A8 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
UY27993A1 (es) Derivados de 4-pirrolidino-fenil-bencil eter
WO2006055434A3 (en) Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
CL2008001960A1 (es) Compuestos derivados de tetrahidropiranocromano, procedimiento de preparacion, composicion farmaceutica, util para inhibir gamma-secretasa, destinados al tratamiento de enfermedades neurodegenetarivas, enfermedad de alzheimer e inhibir el deposito de proteina amiloide.
ATE424823T1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin- derivate als arzneimittel zur behandlung von unfruchtbarkeit
NO20076405L (no) Anvendelse av 24-nor-UDCA
WO2006019685A3 (en) Compounds and their preparation for the treatment of alzheimer's disease by inhibiting beta-amyloid peptide production
DK1670903T3 (da) Behandling af neurodegenerative sygdomme
ATE524171T1 (de) Verwendung von 2-(2-nitro-4- trifluormethylbenzoyl)-1,3-cyclohexandion bei der behandlung der parkinson-krankheit
DK1778837T3 (da) Behandling af neurodegenerative sygdomme ved anvendelse af SCD4-inhibitorer
WO2007019080A3 (en) Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
BRPI0509881A (pt) combinação terapêutica para tratamento da doença de alzheimer
WO2007063428A3 (en) Pharmaceutical compositions comprising carboxyalkylsulfonic acids
UA87224C2 (ru) Применение 24-нор-урсодеоксихолевой кислоты для лечения холестатических заболеваний печени
EA201691232A1 (ru) Способы лечения и предупреждения нейродегенеративных заболеваний и нарушений
EA201400009A1 (ru) Способы лечения и предупреждения нейродегенеративных заболеваний и нарушений